Skip to main content

Advertisement

Table 2 Levels of KLK6, KLK8 and KLK10 in CSF of NC and patients with AD stratified to the A/T/(N) system

From: Kallikrein-related peptidases 6 and 10 are elevated in cerebrospinal fluid of patients with Alzheimer’s disease and associated with CSF-TAU and FDG-PET

  AD A+/T+/N+ (n = 21) AD A+/T−/N+ (n = 11) NC A−/T−/N- (n = 23)
CSF-KLK6 ng/ml 372 ± 106.2 (243–663) 224 ± 56.7 (132–312) 220 ± 62.4 (101–344)
CSF-KLK8 ng/ml 0.16 ± 0.024 (0.12–0.21) 0.16 ± 0.031 (0.12–0.22) 0.16 ± 0.058 (0.10–0.37)
CSF-KLK10 ng/ml 0.69 ± 0.220 (0.32–1.11) 0.61 ± 0.26 (0.22–1.03) 0.48 ± 0.249 (0.08–0.95)
  1. KLK Kallikrein-related peptidase, AD Alzheimer’s dementia, NC normal controls, A amyloid pathology, T Tau pathology, N Neuronal injury